This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks Advance to Start Second Half as Global Growth Strengthens

Stocks in this article: ^DJI ^GSPC ^IXIC BBY INTU C INSM

NEW YORK ( TheStreet) -- Major U.S. stock markets were rising to start July and the second half of 2013 on Monday as investors embraced reports showing manufacturing and spending growth across developed economies.

The S&P 500 rose 0.5% to close at 1,614.96 as the Dow Jones Industrial Average added 0.4% to 14,974.96. The Nasdaq was tacking on 0.9% to 3,434.49.

Best Buy (BBY) climbed to a two-year high surging 8.8% to $29.74 after shares of the electronic retailer were reinstated at Credit Suisse with an "outperform" recommendation. The Credit Suisse analysts said the stock has become their "best near term idea."

Intuit (INTU) jumped 3.5% to $63.15 after the business and financial management solutions company announced it has agreed to sell Intuit Financial Services to private equity firm Thoma Bravo for $1.025 billion, pending regulatory review. Intuit said the move reflects the firm's goal to intensify its focus on its small business and consumer tax businesses.

"With earnings season just around the corner, future Fed policy uncertain, and economic data still mixed, we suggest volatility is likely to remain relatively high in the seasonally weak summer months," Gina Martin Adams, New York-based senior analyst at Wells Fargo Securities, cautioned in a note. But she wrote that she's sticking to her defensive and domestic sector recommendations, with an overweight rating on financials, health care and consumer staples.

The European markets were higher after Markit's final eurozone Purchasing Managers' Index showed an increase to a 16-month high of 48.8 in June from May's estimate of 48.3. The FTSE 100 in London was rising 1.45% and the DAX in Germany was gaining 0.33%.

The Nikkei 225 in Japan increased to a one-month high Monday, settling up 1.28% to 13,852.50 as investors were encouraged by an upbeat business sentiment survey, and Prime Minister Shinzo Abe and the Bank of Japan's aggressive stimulus measures. The Shanghai Composite showed resiliency, erasing earlier losses despite concerns about a slowing economy to settle at a one-week high, up 0.81% to 1,995.24. Overnight, the final estimate on the China HSBC PMI for June fell to a nine-month low of 48.2.

In the U.S., the Institute for Supply Management's ISM Manufacturing Index showed that conditions in the manufacturing sector improved in June, rising back above 50 last month after spending one month below the 50 mark. The gauge rose to 50.9 in June from 49 in May, beating the average economist expectation of 50.5 for June. But beneath the headline number lay mixed subcomponent data, with new orders rising back above 50 but the employment index falling below 50.

Meanwhile the Census Bureau reported that construction spending increased by 0.5% in May after edging up by a downwardly revised 0.1% in April. A rise of 0.6% for May was expected.

Before the open, the final Markit U.S. Manufacturing Purchasing Managers' Index for June posted a reading of 51.9, signaling a modest expansion for the month. But having fallen from 52.3 in May, and dropping below the earlier flash estimate of 52.2, the PMI indicated the slowest rate of growth since last October.

Investors on Monday are also looking ahead to the unofficial start to the second-quarter earnings season on July 8, with Alcoa's (AA) earnings report as well as the official June nonfarm payrolls report this Friday.

Citigroup (C) advanced 0.6% to $48.25. The bank said it will pay Fannie Mae (FNMA) nearly $1 billion to resolve potential repurchase claims on faulty mortgages sold to the housing giant between 2000 and 2012.

Insmed ( INSM) was plunged 19% to $9.72 after an experimental, once-daily antibiotic from Insmed was judged to be statistically equivalent to a currently approved, twice-daily antibiotic from Novartis ( NVS ) in treating cystic fibrosis patients with serious lung infection, according to results from a phase III study announced Monday.

Written by Andrea Tse in New York

>To contact the writer of this article, click here: Andrea Tse.>.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs